Brief: Beroni Group Signs MoU With Tella, Inc To Collaborate In Immunotherapy For Cancer Treatment
28/05/2021 13:44
May 28 (Reuters) - Beroni Group Ltd BTG.NH :
* BERONI GROUP SIGNS MOU WITH TELLA, INC TO COLLABORATE IN
IMMUNOTHERAPY FOR CANCER TREATMENT
Source text for Eikon: ID:nGNXbb6WfB
Further company coverage: BTG.NH
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beroni
See all newsBrief: Beroni Group’s Enhanced Covid-19 Antigen Rapid Test Kit Received CE Certification
Brief: Beroni Group Ltd Files For A U.S. IPO
Received Part Payment Of A $1.07 Mln Order For SARS-COV-2 Antigen Test Kit From A Japanese Pharma Co
Brief: Beroni Group Gets Approval For R&D Rebate From Australian Government
Brief: Beroni Group Says Study Of Its SARS-CoV-2 Antigen Test Kit Showed Overall Sensitivity Of 95%